Oglufanide disodium

N/A

Report date: 2024/06/27 20:00:09
NME

Base Information

Drug NameOglufanide disodium
Drug Alias NameTimogen奥谷法奈二钠Glufanide奥谷法奈Thymogen +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulatorsAngiogenesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsOvarian NeoplasmsColorectal NeoplasmsAbdominal Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[4] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlza CorpCytran Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Southern CaliforniaCytran Inc
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsColorectal NeoplasmsAbdominal Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG